Cuprina to Acquire Seven-Clinic Singapore Healthcare Group


Show Chart?
Load external content from TradingView!
*You can change or withdraw your consent at any time in the footer under Cookies.
Cuprina to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group
Singapore, October 2, 2026 - Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR), a biomedical company, announced that it has entered into Sale and Purchase Agreements to acquire 100% of East Coast Podiatry Centre Pte. Ltd. and Orchard Clinic Management Pte. Ltd., operating a total of seven clinics in Singapore, for approximately S$4.0 million (US$3.1 million).
The acquisition combines S$3.0 million in cash and S$1.0 million in Class A ordinary shares of the Company. The target group generated unaudited revenue of approximately S$9.1 million and normalized EBITDA of approximately S$1.2 million for fiscal year 2025.
This strategic move integrates established clinical platforms directly aligned with Cuprina's wound-care and collagen technologies, expanding the company into an integrated healthcare platform.
Acquisition Highlights
- Acquiring 100% of East Coast Podiatry (five clinics) and Orchard Clinic (two clinics).
- Total purchase consideration of approximately S$4.0 million.
- Target group generated FY2025 unaudited revenue of S$9.1 million and normalized EBITDA of S$1.2 million.
- Completion expected on or before November 1, 2026.
About Cuprina Holdings (Cayman) LTD
More CUPR News
Biotechnology
Acquisition

Daily overview of upcoming SPAC and IPO events – from initial announcement to definitive agreement and public listing.

Discover last week’s SPAC and IPO highlights, key trends, and market updates. Stay informed with SpacStar.
















